chr6-20546466-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_017774.3(CDKAL1):c.116G>A(p.Arg39Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00769 in 1,614,084 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0079 ( 51 hom. )
Consequence
CDKAL1
NM_017774.3 missense
NM_017774.3 missense
Scores
3
2
12
Clinical Significance
Conservation
PhyloP100: 7.95
Genes affected
CDKAL1 (HGNC:21050): (CDK5 regulatory subunit associated protein 1 like 1) The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006807238).
BP6
Variant 6-20546466-G-A is Benign according to our data. Variant chr6-20546466-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 773467.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-20546466-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDKAL1 | NM_017774.3 | c.116G>A | p.Arg39Gln | missense_variant | 3/16 | ENST00000274695.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDKAL1 | ENST00000274695.8 | c.116G>A | p.Arg39Gln | missense_variant | 3/16 | 1 | NM_017774.3 | P1 | |
CDKAL1 | ENST00000613575.4 | c.116G>A | p.Arg39Gln | missense_variant | 4/6 | 1 | |||
CDKAL1 | ENST00000378610.1 | c.116G>A | p.Arg39Gln | missense_variant | 1/14 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00570 AC: 868AN: 152174Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
868
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00539 AC: 1354AN: 251394Hom.: 2 AF XY: 0.00535 AC XY: 727AN XY: 135878
GnomAD3 exomes
AF:
AC:
1354
AN:
251394
Hom.:
AF XY:
AC XY:
727
AN XY:
135878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00789 AC: 11536AN: 1461792Hom.: 51 Cov.: 30 AF XY: 0.00778 AC XY: 5659AN XY: 727204
GnomAD4 exome
AF:
AC:
11536
AN:
1461792
Hom.:
Cov.:
30
AF XY:
AC XY:
5659
AN XY:
727204
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00571 AC: 869AN: 152292Hom.: 4 Cov.: 33 AF XY: 0.00520 AC XY: 387AN XY: 74468
GnomAD4 genome
AF:
AC:
869
AN:
152292
Hom.:
Cov.:
33
AF XY:
AC XY:
387
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
29
ALSPAC
AF:
AC:
41
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
87
ExAC
AF:
AC:
651
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;N
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N
REVEL
Benign
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
P;D;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at